These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 35353392)

  • 1. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells.
    Bernal-Chico A; Tepavcevic V; Manterola A; Utrilla C; Matute C; Mato S
    Glia; 2023 Jan; 71(1):103-126. PubMed ID: 35353392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and glial cells: possible mechanism to understand schizophrenia.
    de Almeida V; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2018 Oct; 268(7):727-737. PubMed ID: 29392440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
    Khan H; Ghori FK; Ghani U; Javed A; Zahid S
    Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system as a target for the treatment of neurodegenerative disease.
    Scotter EL; Abood ME; Glass M
    Br J Pharmacol; 2010 Jun; 160(3):480-98. PubMed ID: 20590559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid signaling in microglial cells.
    Stella N
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):244-53. PubMed ID: 18722389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
    Basavarajappa BS; Nixon RA; Arancio O
    Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
    Di Marzo V
    Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Druggable Targets in Endocannabinoid Signaling.
    Gregus AM; Buczynski MW
    Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid-Binding Receptors as Drug Targets.
    Gómez-Cañas M; Rodríguez-Cueto C; Satta V; Hernández-Fisac I; Navarro E; Fernández-Ruiz J
    Methods Mol Biol; 2023; 2576():67-94. PubMed ID: 36152178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptors and endocannabinoids: evidence for new players.
    Mackie K; Stella N
    AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Δ
    Huerga-Gómez A; Aguado T; Sánchez-de la Torre A; Bernal-Chico A; Matute C; Mato S; Guzmán M; Galve-Roperh I; Palazuelos J
    Glia; 2021 Mar; 69(3):532-545. PubMed ID: 32956517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.